Skip to content
PeptideSport
SHED logo

Provider review

SHED review

A real month-to-month rate exists — it is just not the one on the banner

Tirzepatide is $299/month with no prepay; the advertised "as low as $239" requires paying for a full year up front, $2,868 in one go.

Verified July 2026Partner

Straight talk: how we earn — some, not all, of these are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

On this page

The verdict

SHED does something most of this category does not: it publishes its commitment tiers as an explicit table rather than burying them, so you can see that $299 is the month-to-month rate, $269 buys a six-month prepay and $239 buys twelve. That honesty in the table is undercut by the marketing above it, where the banner leads with "as low as $239/mo" — a number that requires $2,868 in a single payment. The semaglutide side is messier still: a site-wide banner advertises $159/mo, the actual purchasable product is "Starting at $199/month", and that product is a generic "GLP-1 Injections" SKU whose own description leaves the specific drug to be determined, with semaglutide listed as one possibility rather than a guarantee.

SHED appears on our tirzepatide provider ranking, our semaglutide provider ranking, our NAD+ provider ranking, our weight-loss ranking for women and our weight-loss ranking for men. Nothing on this page is a performance claim — see the evidence review for what these compounds do and do not do.

Who it is for, and who it is not

A good fit if

  • You want a genuine month-to-month option and are happy to pay $299 for the flexibility
  • You want to see the prepay tiers laid out as a table before deciding, rather than discovering them at checkout
  • You want the consult and provider review bundled into the price

Look elsewhere if

  • You are comparing on the advertised headline — $239 and $159 are not rates you can simply sign up for
  • You want a guarantee of which molecule you are being dispensed before you buy
  • You want dose-tiered pricing confirmed at a maintenance dose

What it actually costs

What they advertise

Tirzepatide: $299/month month-to-month, $269 on a 6-month plan, $239 on a 12-month plan. Semaglutide: $199/month month-to-month, $179 on 6 months, $159 on 12. Site banners advertise "as low as $239" and "as low as $159" — both are the twelve-month figures.

What you actually pay, month to month

$299/month for tirzepatide and $199/month for semaglutide, with no prepayment required for either.

The commitment trap

Both advertised headlines are twelve-month plan rates. "As low as $239" is 20% below the $299 you actually pay month to month, and "as low as $159" is 20% below $199. Credit where it is due: the tiers themselves are published as a plain table on the product pages rather than gated behind a quiz, so the real number is findable — it is just not the one in the banner.

Money you will meet later

  • The consult and provider review are bundled; no separate fee was found
  • Discount tiers are by commitment length, not by dose — the site acknowledges titration but publishes no per-mg pricing
  • Free shipping is stated on the drops and lozenge formats
  • A 120-day money-back "Shed Promise" is published, with terms effective June 2026
  • Other formats are priced separately: lozenges $199/mo and liquid drops $229/mo

Checked live on SHED's own site at https://www.tryshed.com/products/compounded-tirzepatide-injections in July 2026. Prices change without notice — confirm before you buy. Work out what a vial actually gives you with our peptide dose calculator.

What is included

The cheapest headline number in this category is often the one with the least attached to it. Here is what SHED bundles in, and what it does not.

Clinician consult

Bundled into the monthly price, with no separate consult fee…

found.

Bloodwork / labs

Optional

— no lab requirement is published as a gate.

Follow-ups and dose changes

Included in the programme price as described.

Human support

No dietitian or coaching programme is published.

Injection supplies

Not itemised on the product page.

Shipping

Not stated as a separate charge.

Pharmacy, labs and oversight

The pharmacy

Not publicly named. No 503A or 503B designation appears on the site.

Oversight

Bundled into the monthly price, with no separate consult fee found. Included in the programme price as described.

Compounded peptides are not FDA-approved products, and a 503A pharmacy compounds for a named patient while a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Our guide to verifying a certificate of analysis covers what to ask for.

Where you can get it

No ship-to state list is published on the pages reviewed.

The honest cons

The part they would rather you skipped

The semaglutide product is not sold as semaglutide. It is a generic "GLP-1 Injections" SKU whose own description says the best option "will be determined", listing semaglutide as one possibility among others — and the same weight-loss menu also sells Foundayo® (orforglipron), a different oral GLP-1 molecule entirely, at $149/mo plus a $125/mo membership. A reader who clicks a semaglutide banner, lands on a GLP-1 product and pays $199 has no written commitment about which drug arrives. The compounding pharmacy is not publicly named and the state list is undisclosed, which caps how far the good pricing disclosure can carry the rest. One clarification worth having: shedrx.com and tryshed.com are the same company — shedrx.com 301-redirects — so a board listing both as rivals is double-counting one partner, which is a mistake we have had to correct on two sibling sites.

  • Both advertised headlines ($239 and $159) are 12-month plan rates, 20% below the real monthly ones
  • The GLP-1 product does not guarantee which molecule is dispensed
  • The Foundayo (orforglipron) line carries a $125/mo membership on top of the $149 drug price
  • No published dose-tiered pricing, so whether $299 holds at a maintenance dose is unconfirmed
  • Compounding pharmacy not publicly named and no state list published
  • NAD+ (2026-07-31): the page titled "NAD+ Injections" leads with $144, which is the nasal spray's rate; the injection is $169 — the same banner-versus-product mismatch as the semaglutide line above

None of this is unique to SHED — the whole category shares it. What we hold against a provider is the part it hides, and the ways vendors hide things are catalogued in our vendor red-flags guide.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Facts on this page reflect SHED's own public disclosures when we last checked them, in July 2026. Prices and terms change without notice — confirm on SHED's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.